Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The European Congress on Dermato-Oncology (Dermato-Onco2024) took place on 31 October-1 November 2024 in Vienna, Austria. Dermato-Oncology 2024 will showcase the latest advances in skin cancer diagnosis, treatment, and prevention, covering topics such as genetic predisposition, dermatopathology, surgical and systemic therapies, and emerging treatments. The congress will bring together oncologists, dermatologists, immunologists, and other experts, which VJOncology will cover.

Dermato-Onco2024

31 Oct–01 November 2024 | Vienna, Austria

Dermato-Onco2024

31 Oct–01 November 2024 | Vienna, Austria
The European Congress on Dermato-Oncology (Dermato-Onco2024) took place on 31 October-1 November 2024 in Vienna, Austria. Dermato-Oncology 2024 will showcase the latest advances in skin cancer diagnosis, treatment, and prevention, covering topics such as genetic predisposition, dermatopathology, surgical and systemic therapies, and emerging treatments. The congress will bring together oncologists, dermatologists, immunologists, and other experts, which VJOncology will cover.
Managing skin toxicities during immune checkpoint inhibitor therapy 8:05
Managing skin toxicities during immune checkpoint inhibitor therapy
Yevgeniy Semenov • 8 Nov 2024
A retrospective study on the significant role of adjuvant therapy in melanoma 1:05
A retrospective study on the significant role of adjuvant therapy in melanoma
Gabriele Roccuzzo • 31 Oct 2024
Real-time surveillance with ctDNA in stage III BRAF-positive melanoma 1:29
Real-time surveillance with ctDNA in stage III BRAF-positive melanoma
Gabriele Roccuzzo • 31 Oct 2024
Risk stratification and disease monitoring using ctDNA in cutaneous melanoma 0:36
Risk stratification and disease monitoring using ctDNA in cutaneous melanoma
Gabriele Roccuzzo • 31 Oct 2024
Identifying biomarkers in cutaneous SCC for enhanced patient screening 0:35
Identifying biomarkers in cutaneous SCC for enhanced patient screening
Vasu Divi • 28 Oct 2024
Guidelines for diagnosing skin toxicities during immunotherapy 1:18
Guidelines for diagnosing skin toxicities during immunotherapy
Yevgeniy Semenov • 8 Nov 2024
Impact of de novo autoimmune skin toxicities during therapy with ICIs 1:45
Impact of de novo autoimmune skin toxicities during therapy with ICIs
Yevgeniy Semenov • 8 Nov 2024
Developing personalized treatments for patients with cutaneous SCC 0:40
Developing personalized treatments for patients with cutaneous SCC
Vasu Divi • 28 Oct 2024
Current barriers in using AI to diagnose skin cancers 3:51
Current barriers in using AI to diagnose skin cancers
Harald Kittler • 30 Oct 2024
The potential role of AI in diagnosing melanoma and other skin cancers 1:48
The potential role of AI in diagnosing melanoma and other skin cancers
Harald Kittler • 30 Oct 2024
Future directions in personalized treatment approaches for melanoma 2:01
Future directions in personalized treatment approaches for melanoma
Piotr Rutkowski • 31 Oct 2024
Reducing the need for surgical interventions in the management of melanoma 7:37
Reducing the need for surgical interventions in the management of melanoma
Piotr Rutkowski • 31 Oct 2024
Addressing potential biases in AI models for skin cancer diagnosis 4:22
Addressing potential biases in AI models for skin cancer diagnosis
Harald Kittler • 30 Oct 2024
The future role of neoadjuvant immunotherapies in advanced cSCC 0:43
The future role of neoadjuvant immunotherapies in advanced cSCC
Vasu Divi • 28 Oct 2024
Neoadjuvant atezolizumab for advanced cutaneous squamous cell carcinoma 1:00
Neoadjuvant atezolizumab for advanced cutaneous squamous cell carcinoma
Vasu Divi • 28 Oct 2024
Tissue-based profiling to predict SLN positivity in high-risk melanoma 1:59
Tissue-based profiling to predict SLN positivity in high-risk melanoma
Julian Kӧtt • 5 Nov 2024
The content of VJOncology is intended for healthcare professionals